Key facts
- Toy Medical’s last known valuation is $16.3M (Nov 2025).
- It has raised $5.1M; the latest was Later Stage VC ($2.0M) in Nov 2025.
- Notable investors include Japan External Trade Organization, Leave a Nest Capital, SocialX Acceleration, Glocalink, Higin Capital — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Toy Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Toy Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Toy Medical
Producer of health-focused products designed for dietary and wellness purposes. The company's platform incorporates proprietary salt-offset technology using seaweed-derived alginates, a potassium-free formula, and applications across supplements, seasonings, and snacks, enabling healthcare and wellness markets to manage sodium intake effectively without compromising taste, improve nutritional balance, and support long-term cardiovascular health through natural, science-backed innovations.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Kumamoto, Japan
- Founded
- 2013
- Employees
- 14
- Website
- toymedical.jp/
- Ownership
- Privately Held (backing)
Toy Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Toy Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Toy Medical in its N-PORT filings yet. We sweep new filings monthly.